The role of PDK4 in cancer therapy is complex; the inhibition of PDK4 is sufficient to inhibit the proliferation of and induce apoptosis in lung cancer cells [41], but the overexpression of PDK4 is also able to decrease ATP levels and suppress de novo lipogenesis and proliferation in breast cancer cells [30]. This evidence concerns the gene PDK4 and breast cancer.